Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
P/E Ratio HistoryNormalizing
Percentile Rank17
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-33.72
↓ 17% vs avg
Percentile
P17
Within normal range
Streak
2 yr
Consecutive declineNormalizing
Average
-28.76
Historical baseline
PeriodValueYoY Change
2025-33.72-378.0%
2024-7.06-228.9%
2023-2.15+35.2%
2022-3.31+74.2%
2021-12.85+50.5%
2020-25.98+77.7%
2019-116.25-